|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.425 USD | +3.12% |
|
-3.94% | -32.70% |
| 04:50pm | Ocular Therapeutix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 03:23pm | Ocular Therapeutix's Q2 Net Loss Widens, Revenue Flat | MT |
| Market Cap | 1.79B 1.56B 1.45B 1.33B 2.51B 171B 2.55B 17.06B 6.7B 85.02B 6.72B 6.57B 285B | P/E 2026 * |
-5.1x | P/E 2027 * | -5.8x |
|---|---|---|---|---|---|
| Enterprise Value | 1.43B 1.24B 1.15B 1.06B 2B 136B 2.03B 13.6B 5.34B 67.77B 5.36B 5.24B 227B | EV / Sales 2026 * |
27.5x | EV / Sales 2027 * | 14.7x |
| Free-Float |
99.06% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Ocular Therapeutix, Inc.
| 1 day | -3.54% | ||
| 1 week | -3.94% | ||
| 1 month | -15.25% | ||
| 3 months | -13.36% | ||
| 6 months | -10.71% | ||
| Current year | -32.70% |
| 1 week | 8.15 | 8.66 | |
| 1 month | 8.15 | 10.94 | |
| Current year | 6.23 | 13.03 | |
| 1 year | 6.23 | 16.44 | |
| 3 years | 2 | 16.44 | |
| 5 years | 2 | 16.44 | |
| 10 years | 2 | 24.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pravin Dugel
CEO | Chief Executive Officer | 62 | 15/04/2024 |
Jason Robins
DFI | Director of Finance/CFO | 50 | 20/01/2026 |
Nadia Waheed
CTO | Chief Tech/Sci/R&D Officer | 49 | 20/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Warden
CHM | Chairman | 57 | 01/07/2019 |
| Director/Board Member | 78 | 05/11/2012 | |
Leslie Williams
BRD | Director/Board Member | 66 | 20/03/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 23/02/26 | Sell | Executive/Senior Manager | 1,759 | 0.0008% | ||
| 23/02/26 | Sell | Executive/Senior Manager | 2,810 | 0.0013% | ||
| 23/02/26 | Sell | Chief Technology Officer | 3,057 | 0.0014% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.12% | -3.94% | -31.46% | +90.00% | 1.79B | ||
| -2.08% | -3.95% | +50.70% | +152.78% | 1,024B | ||
| -1.37% | -2.68% | +53.20% | +50.87% | 618B | ||
| -1.59% | -3.25% | +28.54% | +67.99% | 443B | ||
| +0.74% | -0.81% | +40.08% | +33.81% | 349B | ||
| -0.79% | -1.43% | +33.94% | +42.24% | 297B | ||
| -7.92% | -6.71% | +7.97% | +10.31% | 264B | ||
| -0.64% | -5.93% | -1.87% | -42.77% | 209B | ||
| +0.01% | +2.43% | +29.74% | +67.16% | 208B | ||
| +0.06% | +0.70% | +15.05% | +72.05% | 162B | ||
| Average | -0.42% | -1.60% | +22.59% | +54.44% | 357.55B | |
| Weighted average by Cap. | +0.34% | -2.17% | +36.86% | +73.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 51.91M 45.12M 42M 38.56M 72.82M 4.96B 73.95M 495M 194M 2.47B 195M 191M 8.27B | 120M 105M 97.38M 89.4M 169M 11.49B 171M 1.15B 450M 5.72B 452M 442M 19.18B |
| Net income | -362M -314M -293M -269M -507M -34.53B -515M -3.45B -1.35B -17.19B -1.36B -1.33B -57.65B | -331M -287M -267M -246M -464M -31.56B -471M -3.15B -1.24B -15.71B -1.24B -1.21B -52.68B |
| Net Debt | -363M -316M -294M -270M -509M -34.65B -517M -3.46B -1.36B -17.25B -1.36B -1.33B -57.85B | -18M -15.65M -14.56M -13.37M -25.25M -1.72B -25.64M -172M -67.38M -855M -67.6M -66.12M -2.87B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/08/26 | $8.355 | +2.26% | 232,652 |
| 31/07/26 | $8.170 | -3.54% | 2,151,848 |
| 30/07/26 | $8.470 | +1.32% | 2,686,427 |
| 29/07/26 | $8.360 | -1.07% | 1,785,320 |
| 28/07/26 | $8.450 | -2.20% | 2,373,435 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OCUL Stock
Select your edition
All financial news and data tailored to specific country editions

















